MetLife MET Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Net margin | 20.3%-1.5pp | 21.7%-1.9pp | 23.6%+0.1pp | 23.5%+1.6pp | 21.9%+2.6pp | |
| Returns | ||||||
| Return on equity | 53.8%-2.9pp | 56.6%-3.3pp | 59.9%-0.5pp | 60.4%+5.5pp | 54.9%+8.3pp | |
| Return on assets | 2.1%-0.2pp | 2.3%-0.2pp | 2.5%0.0pp | 2.5%+0.2pp | 2.3%+0.3pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 2.2×0.0× | 2.2×0.0× | 2.3×0.0× | 2.2×0.0× | 2.2×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Valuation | ||||||
| Market capitalization | $206.38B-4.0% | $214.96B-2.1% | $219.64B-1.7% | $223.47B+1.2% | $220.75B+0.5% | |
| Enterprise value | $181.5B-5.3% | $191.67B-3.7% | $198.98B-1.1% | $201.28B+0.9% | $199.4B-0.7% | |
| Price / earnings | 54.9×+0.6× | 54.3×+2.6× | 51.7×-1.3× | 53×-5.0× | 58×-10.5× | |
| Price / sales | 2.8×-0.1× | 2.9×-0.1× | 3×-0.1× | 3.1×0.0× | 3.1×0.0× | |
| Price / book | 7.3×-0.3× | 7.6×-0.2× | 7.9×0.0× | 7.9×+0.1× | 7.8×+0.1× | |
| EV / sales | 2.4×-0.2× | 2.6×-0.2× | 2.8×0.0× | 2.8×0.0× | 2.8×-0.1× | |
| Earnings yield | 29.4%-0.4pp | 29.8%-1.3pp | 31.1%+0.6pp | 30.5%+2.3pp | 28.2%+3.8pp | |
| Dividend yield | 11.8%+0.5pp | 11.3%+0.2pp | 11.1%+0.1pp | 10.9%-0.2pp | 11.1%-0.1pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do MetLife's ratios come from?
- Every ratio is computed from MetLife's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
